Vilà M R, Segovia-Silvestre T, Gámez J, Marina A, Naini A B, Meseguer A, Lombès A, Bonilla E, DiMauro S, Hirano M, Andreu A L
Department of Neurology, Columbia University College of Physicians & Surgeons. New York, NY, USA.
Neurology. 2003 Apr 8;60(7):1203-5. doi: 10.1212/01.wnl.0000055928.58122.47.
Mutations in the thymidine kinase 2 (TK2) gene cause a myopathic form of the mitochondrial DNA depletion syndrome (MDS). Here, the authors report the unusual clinical, biochemical, and molecular findings in a 14-year-old patient in whom pathogenic mutations were identified in the TK2 gene. This report extends the phenotypic expression of primary TK2 deficiency and suggests that factors other than TK2 may modify expression of the clinical phenotype in patients with MDS syndrome.
胸苷激酶2(TK2)基因突变会导致线粒体DNA耗竭综合征(MDS)的肌病形式。在此,作者报告了一名14岁患者的异常临床、生化和分子学发现,该患者的TK2基因中鉴定出了致病突变。本报告扩展了原发性TK2缺乏的表型表达,并表明除TK2外的其他因素可能会改变MDS综合征患者临床表型的表达。